Sugi Predict

Sugi Predict / Compounds / SCHEMBL20158877

SCHEMBL20158877

SCHEMBL20158877

CCC(C)N1CCC(OC(=O)NC(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 2/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.40
▸ DPP4 P27487 2/20 0.39
▸ KCNA3 P22001 1/20 0.38
▸ RET P07949 1/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MAOB P27338 1/20 0.36
▸ UGT8 Q16880 2/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ BCHE P06276 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CHRM3 P20309 2/20 0.34
▸ CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20147696 0.84 HRH3 (0.42) EPHX1HRH3DPP4CYP3A4TSHR
SCHEMBL22856991 0.81 CYP3A4 (0.39) EPHX1HRH3DPP4KCNA3RET
SCHEMBL20069009 0.79 CHRM3 (0.46) EPHX1DPP4CYP3A4TSHRCYP2C19
SCHEMBL14501550 0.78 EPHX1 (0.47) EPHX1DPP4KCNA3CYP3A4TSHR
SCHEMBL21652040 0.78 CYP3A4 (0.40) EPHX1DPP4KCNA3RETCYP3A4
SCHEMBL8243916 0.76 EPHX1 (0.55) EPHX1DPP4KCNA3CYP3A4TSHR
SCHEMBL8395605 0.76 EPHX1 (0.50) EPHX1DPP4KCNA3CYP3A4TSHR
SCHEMBL25567992 0.75 MAOB (0.40) EPHX1DPP4CYP3A4TSHRMAOB
SCHEMBL11153395 0.75 EPHX1 (0.58) EPHX1KCNA3CYP3A4TSHRCYP2C19
SCHEMBL18713002 0.74 EPHX1 (0.54) EPHX1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200383966-A9 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2020-12-10 — — US disclosed
US-20200030311-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA, INC. 2020-01-30 — — US disclosed
US-10172845-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2019-01-08 — — US disclosed
US-20180134703-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200383966-A9 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 EPHX1 1481/4885HRH3 1000/4885DPP4 1963/4885
US-20200030311-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 EPHX1 1481/4885HRH3 1000/4885DPP4 1963/4885
US-10172845-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, BRAF, RAF1 EPHX1 1481/4885HRH3 1000/4885DPP4 1963/4885
US-20180134703-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 EPHX1 1481/4885HRH3 1000/4885DPP4 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.